Search Results - "Lo Dico, M."

Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter survey by Zucali, P.A, Simonelli, M, Michetti, G, Tiseo, M, Ceresoli, G.L, Collovà, E, Follador, A, Lo Dico, M, Moretti, A, De Vincenzo, F, Lorenzi, E, Perrino, M, Giordano, L, Farina, G, Santoro, A, Garassino, M

“…Abstract The pemetrexed-cisplatin chemotherapy is standard of care in first-line (FL) treatment of malignant pleural mesothelioma (MPM). The second-line (SL)…”
Get full text

First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study by Tibaldi, C, Vasile, E, Antonuzzo, A, Di Marsico, R, Fabbri, A, Innocenti, F, Tartarelli, G, Amoroso, D, Andreuccetti, M, Dico, M Lo, Falcone, A

“…This multicenter phase II study evaluated, in chemonaive patients with stage IIIB–IV NSCLC, age ⩾70 and with a performance status 0–2, the activity, efficacy…”
Get full text

Vaccination of calves against bovine herpesvirus-1: assessment of the protective value of eight vaccines by Castrucci, G, Frigeri, F, Salvatori, D, Ferrari, M, Sardonini, Q, Cassai, E, Lo Dico, M, Rotola, A, Angelini, R

“…Eight separate, but related experiments, were carried out in which groups of six calves were vaccinated with one of eight commercial vaccines. In each…”
Get full text

Vaccination trials against bovine herpesvirus-1 by Castrucci, G, Ferrari, M, Salvatori, D, Sardonini, S, Frigeri, F, Petrini, S, Lo Dico, M, Marchini, C, Rotola, A, Amici, A, Provinciali, M, Tosini, A, Angelini, R, Cassai, E

Get full text

A study on latency in calves by five vaccines against bovine herpesvirus-1 infection by Castrucci, G, Frigeri, F, Salvatori, D, Ferrari, M, Lo Dico, M, Rotola, A, Sardonini, Q, Petrini, S, Cassai, E

“…Four bovine herpesvirus-1 (BHV-1) commercial vaccines, three of which (vaccines B, D, E) were modified live vaccines (MLV) and one (vaccine A) identified as a…”
Get full text

9085 A platinum based second line rechallenge chemotherapy improves survival in small cell lung cancer patients by Laverde, N, Torri, V, Lo Dico, M, Galetta, D, Martelli, O, Michetti, G, Aglione, S, Sburlati, P, Fatigoni, S, Farina, G

Get full text

Immunization against bovine herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine by Castrucci, G, Ferrari, M, Marchini, C, Salvatori, D, Provinciali, M, Tosini, A, Petrini, S, Sardonini, Q, Lo Dico, M, Frigeri, F, Amici, A

“…A bovine herpesvirus-1 (BHV-1) vaccine expressing glycoprotein D, the form with the transmembrane anchor removed, was evaluated for inducing immunity in…”
Get full text

1307 POSTER First-line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: a multicenter phase II study by Tibaldi, C, Vasile, E, Lo Dico, M, Antonuzzo, A, Di Marsico, R, Tartarelli, G, Fabbri, A, Mazzoni, E, Andreuccetti, M, Falcone, A

Get full text

The use of immunomodulators in the control of infectious bovine rhinotracheitis by Castrucci, G, Osburn, B.I, Frigeri, F, Ferrari, M, Salvatori, D, Lo Dico, M, Barreca, F

“…Three experiments have been carried out to verify the effectiveness of an immunomodulator, Baypamun (Bayer AG) in limiting the spread of Bovine herpesvirus-1…”
Get full text

A retrospective analysis of second-line chemotherapy for malignant pleural mesothelioma (MPM) by La Verde, N. M., Bramati, A., Cinquini, M., Tiseo, M., Collovà, E., Michetti, G., Lo Dico, M., Follador, A., Garassino, M. C., Zucali, P.

“…Abstract only…”
Get full text

Outcomes of small cell lung cancer (SCLC) patients treated with second-line chemotherapy (SL): A retrospective analysis of 166 patients by Garassino, M. C., Michetti, G., Lo Dico, M., Califano, R., Aglione, S., Borgonovo, K., Mancuso, A., Galetta, D., Gallerani, E., Collovà, E., Torri, V.

“…Abstract only e19093 Background: Patients with SCLC progressed after first-line chemotherapy (FL) have a poor prognosis and the evidence of a benefit of SL is…”
Get full text

First-line chemotherapy with planned sequential administration of gemcitabine (G) followed by docetaxel (D) in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study by Vasile, E., Tibaldi, C., Antonuzzo, A., Di Marsico, R., Tartarelli, G., Fabbri, A., Lo Dico, M., Mazzoni, E., Andreuccetti, M., Falcone, A.

“…Abstract only…”
Get full text

Prophylaxis of lipopolysaccharide-induced shock by α-galactosylceramide by Sireci, Guido, La Manna, Marco Pio, Di Liberto, Diana, Lo Dico, Marco, Taniguchi, Masaru, Dieli, Francesco, Salerno, Alfredo

“…The NKT cell ligand α‐galactosylceramide and its synthetic homologue KRN7000 stimulate rapid and copious secretion of IFN‐γ and TNF‐α release, both of which…”
Get full text

148PD OUTCOMES OF SMALL CELL LUNG CANCER (SCLC) PATIENTS TREATED WITH SECOND-LINE CHEMOTHERAPY (SL): A RETROSPECTIVE ANALYSIS OF 166 PATIENTS by Garassino, M.C, Califano, R, Michetti, G, Borgonovo, K, Dico, M. Lo, Fatigoni, S, Martelli, O, Ghidini, A, Bareggi, C, Torri, V

Get full text